Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell. 2013 May 9;153(4):828-39. doi: 10.1016/j.cell.2013.04.015.

Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Author information

  • 1Harvard Stem Cell Institute, Brigham and Women's Hospital, Boston, MA 02115, USA.

Abstract

The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 weeks of exposure to the circulation of young mice, cardiac hypertrophy in old mice dramatically regressed, accompanied by reduced cardiomyocyte size and molecular remodeling. Reversal of age-related hypertrophy was not attributable to hemodynamic or behavioral effects of parabiosis, implicating a blood-borne factor. Using modified aptamer-based proteomics, we identified the TGF-β superfamily member GDF11 as a circulating factor in young mice that declines with age. Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.

Copyright © 2013 Elsevier Inc. All rights reserved.

PMID:
23663781
[PubMed - indexed for MEDLINE]
PMCID:
PMC3677132
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk